RX3 Stock Overview
REX American Resources Corporation, together with its subsidiaries, produces and sells ethanol in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
REX American Resources Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$52.50 |
| 52 Week High | US$56.00 |
| 52 Week Low | US$24.80 |
| Beta | 1.08 |
| 1 Month Change | 26.20% |
| 3 Month Change | 29.95% |
| 1 Year Change | 105.08% |
| 3 Year Change | 140.46% |
| 5 Year Change | 108.09% |
| Change since IPO | 1,614.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| RX3 | DE Oil and Gas | DE Market | |
|---|---|---|---|
| 7D | -0.9% | -0.3% | -2.0% |
| 1Y | 105.1% | -36.7% | -0.3% |
Return vs Industry: RX3 exceeded the German Oil and Gas industry which returned -36.7% over the past year.
Return vs Market: RX3 exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| RX3 volatility | |
|---|---|
| RX3 Average Weekly Movement | 10.8% |
| Oil and Gas Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RX3's share price has been volatile over the past 3 months.
Volatility Over Time: RX3's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 117 | Zafar Rizvi | www.rexamerican.com |
REX American Resources Corporation, together with its subsidiaries, produces and sells ethanol in the United States. The company also offers corn, distillers grains, ethanol, distillers corn oil, gasoline, and natural gas. In addition, it provides dry distillers grains with solubles, which is used as a protein in animal feed.
REX American Resources Corporation Fundamentals Summary
| RX3 fundamental statistics | |
|---|---|
| Market cap | €924.16m |
| Earnings (TTM) | €57.21m |
| Revenue (TTM) | €782.38m |
16.2x
P/E Ratio1.2x
P/S RatioIs RX3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RX3 income statement (TTM) | |
|---|---|
| Revenue | US$833.38m |
| Cost of Revenue | US$735.17m |
| Gross Profit | US$98.22m |
| Other Expenses | US$37.28m |
| Earnings | US$60.94m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.48 |
| Gross Margin | 11.79% |
| Net Profit Margin | 7.31% |
| Debt/Equity Ratio | 0% |
How did RX3 perform over the long term?
See historical performance and comparison